Video
22 Jul 2024

NanoCelle Introductory video - 2 min 40 sec runtime

NanoCelle® is a unique, patented delivery system with diverse applications.
QUICK FACTS

Improves compound solubility

Improves absorption

Reduces compound side effects

By-passes 1st pass metabolism

Improves Patient compliance

Improved onset

Significant in vitro and in vivo data

RESEARCH HAS SHOWN:

Extensive studies have been conducted, and results differ with different compounds, but over 400,000 NanoCelle® products have been dosed to patients with minimal side effects.

In vitro characterization done in collaboration with the University of Sydney

PK studies showed up too 5 times more compound is absorbed when compared to tablets, capsules, emulsions, and liposomes

Bioequivalence studies showed comparable levels to tablets 10x its dose.

Phase 1/2 studies showed safety, tolerability, and efficacy.

RWE Studies showed safety, tolerability, and efficacy over extended periods of time

The research portfolio showed no reported incident of CARPA.

Content provided by our supplier

Medlab Group PTY LTD

  • AU
  • 2024
    On CPHI since
  • 1 - 24
    Employees
Company types
Biopharmaceutical company
Primary activities
Clinical Research
Marketing Services Provider
Out-licensing specialist

Other Content from Medlab Group PTY LTD (1)